Join our webinar to see how #targetedproteomics meets the demands of modern workflows head-on, offering low variability and high confidence in quantifying known proteins across matrices like #plasma and bioprocess #samples.

Meet our speakers and register: www.evosep.com/webinars/web...

Unlock deeper insights into Targeted Protein Degradation!
In this seminar, Eric Kuhn, Associate Director at Kymera Therapeutics, presents how our #TargetedProteomics services enabled quantification of IRAK4 degradation in PBMC samples from a Phase 1 trial.
👉 biognosys.com/resources/ma...

Precision Meets Depth: Proteomic Solutions for Hard-to-Measure Targets SISCAPA and Biognosys: A Unified Workflow for Accurate Quantitation of Challenging Proteins

Through our partnership with SISCAPA Assay Technologies, Biognosys offers an end-to-end solution for mass spectrometry driven ultra-sensitive, protein quantification across plasma, CSF, serum, dried blood spots, and tissue lysates.

📄 Learn more 👉 biognosys.com/resources/pr...

#TargetedProteomics

Quantitative Assessment of a Novel Device Designed for Patient-centric Sampling of Dried Plasma Using Targeted Proteomics Technological advancements have significantly enhanced proteomics by improving the quality, depth, and timeliness of proteomic data, making mass spectrometry a promising tool for personalized medicine...

Your reading list for summer vacation just got updated!

Check out our latest article where we look in detail at the quantitative performance of the dried plasma card from Capitainer. Fresh off the press today, in Analytical Chemistry.

#proteomics #targetedproteomics #microsampling